ArticleFrontiers in oncology2024

Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study.

Yiwen Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.